Optimal management of dyslipidemia in women and men.

M. R. Haymart, J. Allen, R. S. Blumenthal

Research output: Contribution to journalReview articlepeer-review


Relatively few studies have examined the clinical effectiveness of cholesterol-lowering drugs in women as compared with men. Most clinical trials do indicate that cholesterol lowering reduces clinical events equally effectively in both genders. However, high-density lipoprotein cholesterol and triglyceride levels may have more prognostic significance in women. The recent finding of a higher risk of death in younger women as compared with younger men who sustain a heart attack, combined with the high proportion of morbidity and mortality due to CHD in older women, emphasizes the need for a better understanding of heart disease in women. This review explores the similarities and differences between women and men regarding the management of dyslipidemia.

Original languageEnglish (US)
Pages (from-to)37-42
Number of pages6
JournalThe journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia
Issue number6
StatePublished - Jan 1 1999

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Physiology


Dive into the research topics of 'Optimal management of dyslipidemia in women and men.'. Together they form a unique fingerprint.

Cite this